Carl Zeiss Meditec (ETR:AFX) Stock Price Down 5.7% – What’s Next?

Carl Zeiss Meditec AG (ETR:AFXGet Free Report) dropped 5.7% during mid-day trading on Friday . The stock traded as low as €50.85 ($53.53) and last traded at €50.95 ($53.63). Approximately 489,838 shares changed hands during mid-day trading, an increase of 419% from the average daily volume of 94,405 shares. The stock had previously closed at €54.05 ($56.89).

Carl Zeiss Meditec Stock Performance

The firm’s fifty day moving average price is €60.07 and its 200-day moving average price is €64.44. The company has a market cap of $4.41 billion, a P/E ratio of 21.62, a P/E/G ratio of 2.83 and a beta of 0.98. The company has a current ratio of 3.51, a quick ratio of 2.47 and a debt-to-equity ratio of 6.74.

About Carl Zeiss Meditec

(Get Free Report)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

Recommended Stories

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.